EMAVUSERTIB

UNII:	MH5DMF9JKY
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₄H₂₅N₇O₅
Preferred Substance Name:	EMAVUSERTIB
InChIKey:	SJHNWSAWWOAWJH-MRXNPFEDSA-N
GSRS Full Record:	MH5DMF9JKY i

1801344-14-8
4-oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-
AU-4948
CA-4948
EMAVUSERTIB [USAN]
Emavusertib
Emavusertib [WHO-DD]
N-[5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide
N-[5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide
N-{5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-(morpholin-4-yl)[1,3]oxazolo[4,5-b]pyridin-6-yl}-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide
emavusertib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

EMAVUSERTIB

Synonyms and Mappings

Resources